Information
-
Trademark
-
88534482
-
International Classifications
-
Filing Date
July 24, 2019
4 years ago
-
Transaction Date
April 14, 2024
2 months ago
-
Status Date
April 14, 2024
2 months ago
-
Published for Opposition Date
June 16, 2020
4 years ago
-
Location Date
April 14, 2024
2 months ago
-
First Use Anywhere Date
July 24, 2019
4 years ago
-
First Use In Commerce Date
August 04, 2023
10 months ago
-
Status Code
602
-
Current Location
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
Employee Name
HENRY, NAKIA D
-
Attorney Docket Number
202011101US
Attorney Name
Jason C. Cameron
Law Office Assigned Location Code
O20
-
Owners
Mark Drawing Code
4000
Mark Identification
CANCEROME
Case File Statements
- GS0051: Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Diagnostic test patch for application to the skin for determining allergic reactions; Diagnostic test patch for application to the skin for determining allergies; Therapeutic vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Contrasting agent for ultrasound diagnostic imaging; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test strips for use in the field of early detection of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Radio-isotope markers for therapeutic or diagnostic use; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Veterinary diagnostic reagents
- PM0001: CANCER OME
- GS0011: Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic preparations for scientific use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic preparations used in science; Diagnostic preparations, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
- GS0441: Medical diagnostic services for cancer detection
- GS0101: Diagnostic apparatus for the detection of cancer; Diagnostic apparatus for the detection of periodontal disease; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Diagnostic penlights for medical purposes; Audio oscillators for detecting toxins and pathogens in the body for medical diagnostic purposes; Cytometers for medical diagnostic use; Dynamometers for diagnostic muscle strength testing; Electromagnetic medical diagnostic imaging apparatus; Flow cytometers for medical diagnostic uses; Hematology analyzers for medical diagnostic uses; Medical diagnostic apparatus for analyzing and measuring electrolytes in the body; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic instruments for the analysis of body fluids; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical apparatus for detecting cancer; Medical device for detecting cancer; Medical device for treating cancer; Nuclear medicine diagnostic imaging apparatus; Organoleptic diagnostic testing apparatus for medical, dental or cosmetic use; Orthopedic devices for diagnostic and therapeutic use; Radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imager; Sample preparation device for medical diagnostic uses; Ultrasonic medical diagnostic apparatus; Ultrasound diagnostic apparatus; X-ray diagnostic apparatus
- GS0421: Diagnostic services in the field of machines that detect cancer; Automobile transmission diagnostic services; Computer diagnostic services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Providing a website featuring information about investigational medical devices, diagnostics and drugs; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases
Case File Event Statements
-
4/14/2024 - 2 months ago
62 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
4/14/2024 - 2 months ago
61 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
12/7/2023 - 6 months ago
60 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Type: XELG
-
12/7/2023 - 6 months ago
59 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Type: XELR
-
9/8/2023 - 9 months ago
58 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/8/2023 - 9 months ago
57 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/8/2023 - 9 months ago
56 - SU - NON-FINAL ACTION - WRITTEN
Type: CNRT
-
8/14/2023 - 10 months ago
55 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
8/11/2023 - 10 months ago
54 - USE AMENDMENT FILED
Type: IUAF
-
8/11/2023 - 10 months ago
53 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
1/24/2023 - a year ago
52 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
1/23/2023 - a year ago
51 - SOU EXTENSION 5 GRANTED
Type: EX5G
-
1/11/2023 - a year ago
50 - SOU EXTENSION 5 FILED
Type: EXT5
-
1/11/2023 - a year ago
49 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
8/13/2022 - a year ago
48 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
8/11/2022 - a year ago
47 - SOU EXTENSION 4 GRANTED
Type: EX4G
-
8/11/2022 - a year ago
46 - SOU EXTENSION 4 FILED
Type: EXT4
-
8/11/2022 - a year ago
45 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
1/6/2022 - 2 years ago
44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
1/4/2022 - 2 years ago
43 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
1/4/2022 - 2 years ago
42 - SOU EXTENSION 3 FILED
Type: EXT3
-
1/4/2022 - 2 years ago
41 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
9/25/2021 - 2 years ago
40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
9/24/2021 - 2 years ago
39 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
8/11/2021 - 2 years ago
38 - SOU EXTENSION 2 FILED
Type: EXT2
-
9/23/2021 - 2 years ago
37 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
9/15/2021 - 2 years ago
36 - NOTICE OF REVIVAL - E-MAILED
Type: NREV
-
9/15/2021 - 2 years ago
35 - SOU EXTENSION RECEIVED WITH TEAS PETITION
Type: TPEX
-
9/15/2021 - 2 years ago
34 - PETITION TO REVIVE-GRANTED
Type: PETG
-
9/15/2021 - 2 years ago
33 - TEAS PETITION TO REVIVE RECEIVED
Type: PROA
-
9/13/2021 - 2 years ago
32 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Type: MAB6
-
9/13/2021 - 2 years ago
31 - ABANDONMENT - NO USE STATEMENT FILED
Type: ABN6
-
2/18/2021 - 3 years ago
30 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
2/18/2021 - 3 years ago
29 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Type: EWAF
-
2/18/2021 - 3 years ago
28 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
2/18/2021 - 3 years ago
27 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
2/4/2021 - 3 years ago
26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
2/2/2021 - 3 years ago
25 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
2/2/2021 - 3 years ago
24 - SOU EXTENSION 1 FILED
Type: EXT1
-
2/2/2021 - 3 years ago
23 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
8/11/2020 - 3 years ago
22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
6/16/2020 - 4 years ago
21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/16/2020 - 4 years ago
20 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/27/2020 - 4 years ago
19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/14/2020 - 4 years ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/11/2020 - 4 years ago
17 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/10/2020 - 4 years ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/10/2020 - 4 years ago
15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
11/22/2019 - 4 years ago
14 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
11/22/2019 - 4 years ago
13 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
11/22/2019 - 4 years ago
12 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
11/20/2019 - 4 years ago
11 - PREVIOUS ALLOWANCE COUNT WITHDRAWN
Type: ZZZX
-
11/12/2019 - 4 years ago
10 - WITHDRAWN FROM PUB - OG REVIEW QUERY
Type: PBCR
-
10/30/2019 - 4 years ago
9 - ASSIGNED TO LIE
Type: ALIE
-
10/21/2019 - 4 years ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/21/2019 - 4 years ago
7 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
10/21/2019 - 4 years ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
10/21/2019 - 4 years ago
5 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
10/21/2019 - 4 years ago
4 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
10/14/2019 - 4 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/2/2019 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
7/29/2019 - 4 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP